Ryan Bushey
Digital Editor

Ryan Bushey is a digital editor for Advantage Business Media’s Science Group.  He covers scientific discoveries, emerging technologies and the business of the life sciences sector for R&D Magazine and Drug Discovery & Development along with managing social media for both publications. He’s an experienced journalist whose work has appeared in Business Insider, Slate, and Indiewire.

This could make it the first drug capable of targeting the underlying cause of this destructive genetic disease.
Digital Editor
|
12.12.2017
11:07am
A concept called destabilizing domains (DD) serve as the crux of this platform.
Digital Editor
|
12.6.2017
9:29am
Scientists performed a screening where they sifted through 14,000 small molecule compounds to find a chemical structure that could bind to a specific protein.
Digital Editor
|
11.22.2017
8:00am
Europe’s top agency for evaluating medical products has found a new home.
Digital Editor
|
11.21.2017
11:14am
A new discovery could be the key to creating personalized treatments for diabetes.
Digital Editor
|
11.20.2017
12:58pm
Advertisement
Analysts predict one of the drugs could produce about $1.6 billion in annual sales by 2022.
Digital Editor
|
11.17.2017
10:42am
The current study focused on sodium percarbonate (SPO) and calcium peroxide (CPO).
Digital Editor
|
11.17.2017
8:50am
This is the first significant step emphasizing how healthcare and technology are beginning to converge.
Digital Editor
|
11.14.2017
9:51am
A team of scientists at Penn State discovered that mushrooms contain high amounts of ergothioneine and glutathione, which are both important antioxidants that...
Digital Editor
|
11.13.2017
11:16am
Valeant Pharmaceuticals announced plans to sell off a controversial acquisition.
Digital Editor
|
11.7.2017
9:12am
Building a whole exome from DNA fragments currently requires at least 10 percent tumor DNA in a blood sample.
Digital Editor
|
11.6.2017
12:16pm
COPD has been the primary focus in the initial development stages.
Digital Editor
|
11.3.2017
11:25am
There are currently no screening tests to detect the disease earlier when survival rates can be much higher.
Digital Editor
|
11.2.2017
9:09am
Advertisement
The goal will be to develop, test, and validate a multidisciplinary approach to drug discovery that relies on supercomputing simulations, data science,...
Digital Editor
|
10.27.2017
11:24am
These pharmaceutical companies are taking alternative approaches to developing an effective drug.
Digital Editor
|
10.25.2017
9:02am
Ketamine is used to induce general anesthesia but can also provide powerful pain control in lower doses for patients suffering from a number of painful...
Digital Editor
|
10.24.2017
8:56am
The venture's proprietary platform could identify unique disease targets that can’t be addressed with traditional clinical approaches.
Digital Editor
|
10.20.2017
9:46am
Regeneron will be its sponsor while Aimmune will provide the clinical supply of AR101 and food challenge materials.
Digital Editor
|
10.17.2017
8:50am
Clinical investigators have incorporated these markers into the later stages of clinical trials to assist in reducing sample size and refining the patient...
Digital Editor
|
10.16.2017
11:00am
Some of the companies participating in this effort include AbbVie, Amgen, Celgene Corporation, and Roche.
Digital Editor
|
10.12.2017
11:26am
The product is intended to create a new epilepsy treatment that reduces the number of seizures and enables a faster recovery.
Digital Editor
|
10.10.2017
11:18am
Advertisement
Administration of the medication occurs via a smartphone or similar wireless device.
Digital Editor
|
10.6.2017
10:28am
The dots differ from previous antibiotic treatments because they are able to work selectively on an intracellular level.
Digital Editor
|
10.5.2017
10:30am
One company is working on novel antibiotics that could combat a considerable health crisis.
Digital Editor
|
10.4.2017
11:00am
This data emphasizes how difficult it’s been to launch a new drug for this condition.
Digital Editor
|
9.26.2017
10:10am
Major pharmaceutical companies have encountered considerable difficulties for developing drugs that treat destructive neurological conditions.
Digital Editor
|
9.26.2017
9:02am
A novel therapy could provide some hope in combating a difficult-to-treat symptom of Parkinson’s disease.
Digital Editor
|
9.25.2017
10:20am
The pharmaceutical company plans on submitting a New Drug Application to the FDA in late 2017.
Digital Editor
|
9.20.2017
9:33am
The tool works by measuring immune system biomarkers in blood samples and then uses machine learning algorithms to identify patterns in certain infections.
Digital Editor
|
9.19.2017
9:49am
Findings indicated one receptor was associated with successfully clearing a virus in experiments.
Digital Editor
|
9.18.2017
10:35am
Another pharmaceutical company revealed it would initiate a restructuring strategy designed to cut costs and streamline operations.
Digital Editor
|
9.13.2017
8:53am
A major pharmaceutical company may have an advantage in the competitive lung cancer treatment space. Details of their study were presented at the ESMO 2017...
Digital Editor
|
9.12.2017
8:46am
Data from this study was presented at the European Society for Medical Oncology taking place in Madrid, Spain.
Digital Editor
|
9.12.2017
8:46am
Overall, these total cuts come out to about 8 percent of Eli Lilly’s workforce.
Digital Editor
|
9.8.2017
8:58am
Investors who participated in this financing included existing investors like Medtronic and Boston Scientific.
Digital Editor
|
9.1.2017
8:00am
A team of scientists found a way to create a novel drug delivery system for an array of different conditions.
Digital Editor
|
8.31.2017
8:00am
Researchers presented results from a late stage study named COMPASS at the annual European Society of Cardiology Meeting taking place in Barcelona, Spain.
Digital Editor
|
8.28.2017
11:20am
E.coli carrying the mcr-1 and ndm-5 genes have made it immune to last-resort antibiotics.
Digital Editor
|
8.22.2017
11:25am
Findings from a previous phase IIa proof-of-concept trial indicated the compound is fast-acting and potent across multiple stages of the parasite’s lifecycle.
Digital Editor
|
8.21.2017
10:57am